Onemednet CORP Form 4 insider transactions

Thomas Kosasa, a Director and 10% owner of OneMedNet Corp, purchased 1,449,275 shares of common stock on July 30, 2026 for $0.69 per share.

OneMedNet Corp CEO Aaron Green reported a significant purchase of company common stock on June 23, 2026.

OneMedNet Corp reports a significant stock purchase by Chief Medical Officer Jeffrey Yu, indicating insider confidence in the company's prospects.

OneMedNet Corp director Jeffrey Yu invested $100,000 in the company and acquired 172,414 common shares, while disclaiming beneficial ownership of shares held in a trust for his children.

OneMedNet Corp CEO Aaron Green has acquired a significant number of company shares through multiple transactions in June 2026.

OneMedNet Corp director Thomas Kosasa acquired 158,730 shares through a subscription agreement for $100,000.

Director Thomas Kosasa acquired 268,817 shares of OneMedNet Corp for $250,000 via a subscription agreement.

OneMedNet Corp reports insider transactions including a significant investment by Chief Medical Officer Jeffrey Yu and issuance of shares for prior compensation.

Director Thomas Kosasa significantly increased his stake in OneMedNet Corp through two recent purchases, indicating strong personal conviction in the company's prospects.

OneMedNet Corp's CEO, Aaron Green, sold shares on two occasions in late 2025 to cover tax withholding obligations related to restricted stock unit awards.

OneMedNet Corp's Chief Medical Officer, Jeffrey Yu, significantly increased his direct beneficial ownership through debt conversions, a private placement, and open market purchases, alongside RSU grants.

OneMedNet's Chief Medical Officer, Jeffrey Yu, increased his direct beneficial ownership through multiple open-market purchases and a significant restricted stock unit grant.

OneMedNet Corp's Chief Financial Officer and Director, Robert Lawrence Golden, reported multiple acquisitions of common stock and restricted stock units, significantly increasing his beneficial ownership.

OneMedNet CEO Aaron Green reported significant acquisitions of common stock through restricted stock unit grants and the conversion of a senior secured convertible note.

OneMedNet Corp director Sherry Coonse McCraw was granted restricted stock units as compensation for board service in fiscal years 2024 and 2025.

OneMedNet Corp director Thomas Kosasa significantly increased his beneficial ownership through a series of share acquisitions, loan conversions, and RSU grants.

OneMedNet Corp Director Jair Clarke reported the acquisition of 138,485 common stock shares through restricted stock unit grants for board and committee service.

OneMedNet Director Andrew B. Zeinfeld reported the acquisition of 144,403 restricted stock units (RSUs) through director compensation plans, increasing his beneficial ownership to 381,525 shares.

OneMedNet Director Eric Casaburi significantly increased his beneficial ownership of common stock through a series of open market purchases and restricted stock unit grants.

OneMedNet Corp Director Kenneth Alleyne received a grant of 38,219 restricted stock units as compensation for his fiscal year 2025 board service.

OneMedNet Corp's Chief Medical Officer, Jeffrey Yu, increased his direct beneficial ownership through multiple common stock purchases and a restricted stock unit grant.